Texas Permanent School Fund Acquires 508 Shares of Petmed Express Inc (PETS)
Texas Permanent School Fund increased its holdings in Petmed Express Inc (NASDAQ:PETS) by 3.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,037 shares of the company’s stock after buying an additional 508 shares during the period. Texas Permanent School Fund owned about 0.07% of Petmed Express worth $320,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also modified their holdings of PETS. Capital Investment Advisory Services LLC bought a new position in Petmed Express in the fourth quarter worth approximately $26,000. Financial Gravity Wealth Inc. bought a new position in Petmed Express in the first quarter worth approximately $49,000. Quantamental Technologies LLC acquired a new position in shares of Petmed Express during the fourth quarter worth $71,000. Kessler Investment Group LLC increased its position in shares of Petmed Express by 159.8% during the first quarter. Kessler Investment Group LLC now owns 3,336 shares of the company’s stock worth $76,000 after purchasing an additional 2,052 shares in the last quarter. Finally, Advisory Services Network LLC increased its position in shares of Petmed Express by 39.3% during the fourth quarter. Advisory Services Network LLC now owns 3,543 shares of the company’s stock worth $82,000 after purchasing an additional 1,000 shares in the last quarter. 99.65% of the stock is owned by institutional investors.
A number of equities analysts have recently issued reports on the company. BidaskClub downgraded Petmed Express from a “sell” rating to a “strong sell” rating in a research report on Thursday. ValuEngine downgraded Petmed Express from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Three investment analysts have rated the stock with a sell rating and two have given a hold rating to the company. The stock presently has a consensus rating of “Sell” and an average price target of $18.00.
Petmed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, May 6th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.14). The business had revenue of $64.57 million for the quarter, compared to analyst estimates of $69.06 million. Petmed Express had a return on equity of 28.96% and a net margin of 13.32%. The business’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.50 earnings per share.
The firm also recently declared a quarterly dividend, which was paid on Friday, May 24th. Stockholders of record on Friday, May 17th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 6.07%. The ex-dividend date of this dividend was Thursday, May 16th.
About Petmed Express
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Further Reading: Outstanding Shares and The Effect on Share Price
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.